Clinical variables | Clinical outcomes | P | OR/HR (95% CI) |
---|---|---|---|
Risk stratifications | OS (mean day ± SE) | 0.027 |  |
 Low + intermediate | 1473 ± 82 |  | 1.00 (reference) |
 High | 1048 ± 113 |  | 2.325 (1.103–4.900) |
Risk stratifications | PFS (mean day ± SE) | 0.013 |  |
 Low | 1532 ± 151 |  | 1.00 (reference) |
 Intermediate | 1096 ± 99 | 0.056 | 2.762 (0.974–7.834) |
 High | 740 ± 105 | 0.005 | 4.801 (1.606–14.350) |
Platelets, ×109/L | CR (%) |  |  |
 < 38.5 | 78.6 |  | 1.00 (reference) |
 ≥ 38.5 | 92.2 | 0.006 | 3.225 (1.362–7.635) |
Risk stratifications
 | Liver function damage (%) | 0.009 |  |
 Low | 22.9 |  | 1.00 (reference) |
 Intermediate | 5.9 | 0.008 | 0.213 (0.071–0.638) |
 High | 15.1 | 0.355 | 0.660 (0.202–1.784) |
Risk stratifications | Cardiotoxicity (%) | 0.004 | Â |
 Low | 17.1 |  | 1.00 (reference) |
 Intermediate | 2.5 | 0.005 | 0.126 (0.030–0.535) |
 High | 3.8 | 0.079 | 0.190 (0.036–1.001) |